MOVE vs REGN · rev $80.0K vs P/E 14, rev $14.34B
Movano Inc (MOVE) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Movano Inc (MOVE) is a software - infrastructure company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported MOVE revenue for 2025-09-30 was $80.0K. Net income was -$4.0M. Revenue was down 22.3% from 2025-06-30 to 2025-09-30. MOVE currently screens at market cap $46.1M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
MOVE currently screens at market cap $46.1M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the MOVE and REGN stock pages for the full models.
Not investment advice.